The new findings in recent years raise more questions about the actual function of GLP-1 and GLP1-RA on taste regulation, like the molecular mechanisms in which the decrease or hypersensitivity of some flavors results from receptor internalization, downregulation of ion channels (such as TRPM5), alterations in neurotransmitter release (ATP/5-HT) (162, 173) or either way for genetic variations and polymorphisms or if it is dependent on the density of specific subpopulations around TBC, since not all patients experience the same effect with medication (151, 158, 176)
Pharma market-access analytics typically define Time-to-Approved Fill (TTAF) or Paid-claim Fill Rate as key KPIs
The results from clinical trials speak volumes, as individuals experienced weight loss of up to 24%, a feat that could reshape lives and perspectives.
How do I start using Shotsy
While she could tolerate the 0.25 mg initiation dose, even that level increased her risk of hypoglycemia
When it comes to reducing side effects, microdosing GLP-1s may backfire